Results 1 to 10 of about 2,223,573 (201)

Retraction Note: EGFR and MET receptor tyrosine kinase-altered microRNA expression induces tumorigenesis and gefitinib resistance in lung cancers. [PDF]

Nat Med, 2022
Garofalo M, Romano G, Di Leva G, Nuovo G, Jeon YJ, Ngankeu A, Sun J, Lovat F, Alder H, Condorelli G, Engelman JA, Ono M, Rho JK, Cascione L, Volinia S, Nephew KP, Croce CM.   +16 more
europepmc   +1 more source

TFAP2C activates PTGES through the NOTCH3 signaling pathway to affect gefitinib resistance in lung adenocarcinoma. [PDF]

J Clin Biochem Nutr
Xiao J, Cao J, Zhu L, Hou J.
europepmc   +1 more source

MiR-323a regulates ErbB3/EGFR and blocks gefitinib resistance acquisition in colorectal cancer. [PDF]

Cell Death Dis, 2022
Zhang Y, Liang S, Xiao B, Hu J, Pang Y, Liu Y, Yang J, Ao J, Wei L, Luo X.   +9 more
europepmc   +1 more source

TLE1 corepressor promotes gefitinib resistance in lung cancer A549 cells via E‑cadherin silencing. [PDF]

Biomed Rep
Yao X, Roberts N, Iheukwumere P, Carmouche A, Chen R, Dela Cruz MC, Biliran H.   +6 more
europepmc   +1 more source

CXCR4 promotes gefitinib resistance of Huh7 cells by activating the c-Met signaling pathway. [PDF]

FEBS Open Bio, 2021
Zhao D, Yang Z, Chen C, Zhang Z, Yu Y, Li Z.   +5 more
europepmc   +1 more source

Identification of Gefitinib Resistance-Related lncRNA-miRNA-mRNA Regulatory Networks and Corresponding Prognostic Signature in Patients with Lung Adenocarcinoma. [PDF]

Int J Gen Med, 2022
Wang T, Wu Z, Li S, Chen Z, Chen Y, Yang Z.   +5 more
europepmc   +1 more source

CIB2 mediates acquired gefitinib resistance by inducing ZEB1 expression and epithelial-mesenchymal transition. [PDF]

Aging (Albany NY)
Zhou FM, Wang KK, Wang LH, Qiu JG, Wang W, Liu WJ, Wang L, Jiang BH.   +7 more
europepmc   +1 more source

Nanoenabled intracellular zinc bursting for efficacious reversal of gefitinib resistance in lung cancer. [PDF]

Int J Biol Sci
Li J, Assaraf YG, Zuo W, Lin Z, Leong KW, Zhao Q, Zhu L, Kwok HF.   +7 more
europepmc   +1 more source

LPIN1 Induces Gefitinib Resistance in EGFR Inhibitor-Resistant Non-Small Cell Lung Cancer Cells. [PDF]

Cancers (Basel), 2022
Cho JH, You YM, Koo H, Lee DC, Yeom YI, Park KC.   +5 more
europepmc   +1 more source

METTL1/FOXM1 promotes lung adenocarcinoma progression and gefitinib resistance by inhibiting PTPN13 expression. [PDF]

Cancer Med
Peng W, Fu J, Zhou L, Duan H.
europepmc   +1 more source